Intuitive Surgical Q3 2026 Performance: Analyzing Robot Placements and Recurring Revenue Growth
Intuitive Surgical (ISRG) recently experienced a stock sell-off following its third-quarter 2026 earnings report, leaving the stock down approximately 20% from its 52-week high. While investors have expressed concerns regarding high valuation multiples and increasing competition from Medtronic (MDT) and Johnson & Johnson (JNJ), the company's core growth metrics remain strong. The company placed 546 da Vinci surgical systems in Q3 2026, an increase from 427 in the previous year. More importantly, its total installed base grew 12% year-over-year to 12,094 units. Because new robot sales account for only about 25% of revenue, the company's long-term value is increasingly driven by a 'flywheel' effect: a growing installed base that generates recurring revenue through instruments, accessories, and services.
Topics: earnings report installed base medical devices surgical robotics
Read the full article at Motley Fool
Part of the story Artmarket.com Announces Q3 2026 Revenue Growth and Upcoming Launch of AI-Driven Visual Search Tool (35 articles)